baber/WOPTO huggingface dataset:
Patent NZ-331810-A (NZ)
Title: Glass decorating method using bis phenol-A epoxy resins and related compositions and articles
Inventor: KAMEN MELVIN E
IPC: C08F2/48
Filed: 1997-03-05
Abstract: This radiation curable ink composition comprises, by weight of the total composition: 1. 30-95 % of a bis phenol-A epoxy resin of formula (I), where n = 0-20, 2. 0.1-25 % of an organofunctional silane of formula (II), wherein n = 0-3, a = 0-2, Y = formula (III); X is each independently CH3, Cl, OCOCH3, OC2H4OCH3, (OC2H4)2OCH3, or -OR, where R is a C1-20 straight or branched chain alkyl, preferably OCH3 or OCH2CH3; 3. 0.1-25 % of a cationic photoinitiator, and 4. 0.05-20 % of a fluorinated surfactant; Also included are methods for and decorated end products produced with the composition
Patent NZ-332544-A (NZ)
Title: Combustion powered nail driver with delayed trigger return to allow piston to return to start position
Inventor: SHKOLNIKOV YURY
IPC: B25C1/04
Filed: 1998-10-29
Abstract: The specification describes a combustion powered nail driver as depicted above.  The nail driver has a pneumatic check valve 74 that delays the return of the trigger 78 from the On to the OFF position.  The pneumatic check valve has a plunger 112 working in cylinder 122.  A seal 120 around the plunger 112 allows air displaced by the plunger to escape past it when the trigger is depressed.  When the trigger is released, the seal allows air to flow back slowly into the cylinder.  This delays the return of the trigger to the OFF position.  A linkage between the trigger and the inlet valve of the combustion chamber prevents the inlet valve from opening until the trigger is in its OFF position.  The delay in the return of the trigger allows time for the driver piston to return to its start position after driving the nail.
Patent NZ-334297-A (NZ)
Title: Acoustic mount with clip, sound absorbing insert and bush with insert installed in orifice in clip and bush installed in orifice in insert so that bush not in contact with clip
Inventor: RYAN PETER ANTHONY
IPC: F16F7/00
Filed: 1999-02-19
Abstract: An acoustic mount for isolating one part of an acoustic vibration from another is described.  The acoustic mount includes: (i)	a mounting clip (ii)	a sound absorbing insert and (iii)	a bush. The mounting clip has an orifice which receives at least part of the sound absorbing insert.  The sound absorbing insert  has an opening for receiving at least part of the bush.  The bush is not in direct contact with the mounting clip.
Patent NZ-337263-A (NZ)
Title: Sulphonyl urea and adjuvant based solid mixtures
Inventor: BRATZ MATTHIAS
IPC: A01N47/36
Filed: 1998-01-29
Abstract: A stable solid mixture comprising a sulfonylurea compound and an alkylpolyglycoside.
Patent NZ-500444-A (NZ)
Title: Implantable pump for delivering medication to animals, pump controlled by microprocessor
Inventor: JELLIE HUGH PHILIP
IPC: A61M31/00
Filed: 1996-03-25
Abstract: An implantable drug delivery device is intended for implanting within the body of an animal.  The device contains reservoirs 13 for the substances to be delivered, pump 23, and microprocessor 18.  Power may be provided by battery 19.  The microprocessor can be programmed to deliver substances at a specific time, volume and rate of release to effect controlled delivery of the substance at a preferred concentration.
Patent NZ-501383-A (NZ)
Title: Ultra-fine microcrystalline cellulose compositions and process for their manufacture
Inventor: VENABLES AARON C
IPC: A61K47/38
Filed: 1998-06-12
Abstract: Ultra-fine microcrystalline cellulose compositions are disclosed which produce highly stable suspensions and/or dispersions in which substantially all of the microcrystalline cellulose has a particle size not greater than about 0.7  mu m. The compositions inlcude an attriting aid which has a dual functionality, assisting in reducing the size of the cellulose microcrystals and adding a desired property or ingredient to the dispersions or other product in which the compositions are utilized.
Patent NZ-502074-A (NZ)
Title: Chemical formulations for incorporation into adhesives used in the production of wooden materials or wood composites
Inventor: JAETSCH THOMAS
IPC: B27K3/50
Filed: 1999-12-23
Abstract: A formulation used for the production of wooden materials and wood composites comprising; (1) at least one phenolic compound, and (2) at least one compound selected from the group comprising anti-insect, anti-basidiomycetes, anti-termite and anti-fungal agents other than the phenolic compounds of (1), and (3) at least one adhesive selected from the group comprising urea resins, melamine-urea copolymer resins, phenol resins, phenol melamine resins,  resorcinol resins, water-based high polymer isocyanates, vinyl acetate resin emulsions, epoxy resins, urethane resins, olefin maleic anhydride resins, natural substances based adhesives and elastomer type adhesives.
Patent NZ-504317-A (NZ)
Title: Flux for brazing comprising elemental boron and at least one of Mo, W, Co, Ni, Pd, Cu or Ag in any form
Inventor: KOCH JURGEN
IPC: B23K35/30
Filed: 2000-05-03
Abstract: This flux, which is useful in brazing difficult to wet metallic materials with silver and copper based solders, contains; 0.01-10  wt% elemental boron; and 0.01-10 wt% of at least one of Mo, W, Mn, Co, Ni, Pd, Cu or Ag in the form of elements, alloys or compounds.
Patent NZ-507119-A (NZ)
Title: 1-[(4-Piperidinyl)methyl]-4-piperidine derivatives useful for treating gastrointestinal disorders
Inventor: KATO SHIRO
IPC: C07D405/14
Filed: 1999-04-19
Abstract: A 1[(4-piperidinyl)methyl]-4-piperidine derivative or a pharmaceutically acceptable acid addition salt thereof has the formula (I) wherein: Ar is a group of the formula (Ar-1) or (Ar-2); R1 is halogen; R2 and R4 are independently hydrogen or alkyl; R3 is hydrogen, alkyl or alkanoyl; R5 and R6 are independently hydrogen or alkyl; n is 1, 2 or 3; A is -Z-N(Q1)(Q2), -CO-R7 or -(CH2)p-CH(R8)-COR9; Z is -CO-, -CS- or -SO2-, Q1 and Q2 are independently hydrogen alkyl, cycloalkyl, optionally substituted phenyl or a phenylalkyl or Q1 and Q2 together with the nitrogen atom to which they attached form pyrrolidine, piperidine, hexahydroazepine, morpholine, thiomorpholine, or piperazine having optionally a lower alkyl or benzyl substituent on the other nitrogen atom); R7 is hydrogen, optionally substituted alkyl, alkoxy, alkoxycarbonyl, or an optionally substituted phenyl. p is 0, 1, 2, 3, 4 or 5; R8 is hydrogen or alkyl and R9 is alkyl or alkoxy. A pharmaceutical composition thereof is useful for treating diseases caused by the lack of stimulation on serotonin 4 receptors such as gastrointestinal disorders.
Patent NZ-507603-A (NZ)
Title: Light guiding device for a fluorescent light source surmounted by a roof-like reflector
Inventor: HUTER JOHANNES
IPC: A63B22/14
Filed: 1999-04-29
Abstract: Light guiding device for an elongated light source (1), especially a fluorescent tubular lamp, characterised by a body (3) of substantially tubular or tube sector shape of transparent material for substantially coaxially receiving the light source (1) and provided at its internal surface with grooves (5), notches or the like extending parallel to the axis and engaging each other.
Patent NZ-509318-A (NZ)
Title: Amide derivatives, their preparation and use in the treatment of diseases mediated by cytokines
Inventor: BROWN DEARG SUTHERLAND
IPC: C07D401/14
Filed: 1999-07-29
Abstract: Amide derivatives of formula (I) and their preparation, where: R3 is alkyl or halo; R2 is hydroxy, halo, trifluoromethyl, cyano, mercapto, nitro, amino, carboxy, alkoxycarbonyl, alkyl, alkenyl, alkynyl, alkoxy or alkylamino; Q1 is heteroaryl, which is optionally substituted with 1, 2, 3, or 4 substituents; p is 0 - 2; q is 0 - 4; and Q2 is optionally substituted aryl, cycloalkyl, heteroaryl and heterocyclyl. The compounds are useful in the treatment of diseases or medical conditions mediated by cytokines.
Patent NZ-510686-A (NZ)
Title: Organosiloxane containing modified groups useful as a pesticide
Inventor: POLICELLO GEORGE A
IPC: C09K23/54
Filed: 1999-09-28
Abstract: A composition contains modified organosiloxanes having the formula (I) [SiO4/2]d[MeSiO3/2]e[O1/2SiMe2Q]g wherein: f is 0 to 50; d is 0 to 2; e is 0 to 3; if the siloxane is not cyclic g = 2+e+2d; if the siloxane is cyclic g  is 0 and f ³ 1; e+d+f+g = 2 to 50 if the siloxane is not cyclic and 4-8 if the siloxane is cyclic; Q is amino alkoxylate of formula -BN[BO(CaH2aO)bR1]2-zTz or R2 with at least one of Q not being R2; each A is 2 to 4 and each b is 2 to 15; each B is an optionally OH substituted divalent hydrocarbon group; z is 0 or 1; R1 is H or hydrocarbon; R2 is polyether of formula -BO(CaH2aO)cR1, H or alkyl; c is 0 to 15 and T is an univalent organic moiety.
Patent NZ-511976-A (NZ)
Title: Baler device for handling a supply roll of wrapping medium which can apply a selective variable force to the surface of the supply roll
Inventor: HUCHET PIERRE-PHILIPPE
IPC: A01F15/07
Filed: 2001-05-25
Abstract: An apparatus for wrapping round bales with wrapping medium includes a) a vertically swingable arm as a brake (38) carrying a contact element arrangement adapted for being applied to a surface of a supply roll (44) of wrapping medium (46) and b) a loading device (62) which is a selectively variable force-applying motor coupled to the swingable arm for forcing the contact element arrangement against the surface of the supply roll.
Patent NZ-514794-A (NZ)
Title: Pharmaceuticals containing nerium extracts and processes for extraction
Inventor: RASHAN LUAY JAMIL
IPC: A61P35/00
Filed: 2001-10-15
Abstract: A method of preparing a sterile water-soluble extract from Nerium orleander containing oleandrin, and other digoxin-like glysosides possessing active glycosides for use in treating several types of tumors comprising the steps of: (i) soaking dried powder (20g) obtained from the species in 100ml of sterile distilled water overnight. (ii) filtering the water solution under sterile conditions. (iii) adjusting the volume of the resultant solution to 30 - 40ml followed by: (iv) millipore filtration under sterile condition, (v) freeze drying of the filtrate under sterile conditions and wherein the active products are extracted from the leaves (16 - 19cm long) of the Nerium oleander harvested during August - December.
Patent NZ-516026-A (NZ)
Title: Oral administration of taxanes to human patients using cyclosporins as bioavailability-enhancing agents
Inventor: BRODER SAMUEL
IPC: A61K31/335
Filed: 1998-04-22
Abstract: Taxane antineoplastic agents which have heretofore exhibited poor or non-existent oral bioavailability are administered orally to human patients suffering from taxane-responsive disease conditions and made sufficiently bioavailable to achieve therapeutic blood or plasma levels are disclosed, wherein the taxane, preferably paclitaxel, is co-administered to the patient with an oral cyclosporin enhancing agent, preferably cyclosporin A; and a dose of oral enhancer is administered about 0.5-72 hours before the taxane and a second dose of the enhancer and administered immediately before, together with or immediately after the taxane.  A method of treating human patients suffering from taxane-responsive disease conditions is also disclosed, as well as a method for providing such treatment while preventing or reducing hypersensitivity and allergic reactions without the need for pre-medication.
Patent NZ-516311-A (NZ)
Title: Improvements to leg supports
Inventor: HOLMES LEO GRANT
IPC: A61H3/02
Filed: 2000-06-02
Abstract: An apparatus (1) for supporting a leg (10), comprises a receptacle (2), and a support (3) attached to the receptacle (2) and including a base (4) and a strut member (5). The receptacle (2) is configured so that a portion of the leg (10) is supported in a non-vertical orientation and secured with straps (16 and 17), with an angle between the receptacle (2) and the support (3) adjustable by an angle adjusting device (6). The apparatus (1) enables a person's leg (10) to be supported at a lower half below the knee (18) as shown, or at an upper half above the knee with thigh protruding forward (not shown). Hence a patient can bear weight or their leg, while keeping weight from the lower half of the leg (10), with the lower half in a position required for a leg injury to recover.
Patent NZ-524309-A (NZ)
Title: Curved hosel putter
Inventor: MOORE SIMON GARRY
IPC: A63B53/06
Filed: 2003-02-21
Abstract: A golf putter, including a shaft, and a putter-head, and a hosel, wherein the hosel is attached at one point in the vicinity of the heel end of the putter-head and at another point to the shaft, characterized in that the hosel is configured so that the centerline of the shaft is aimed at the centre of gravity of the putter.
Patent NZ-531749-A (NZ)
Title: Novel genes and their use in the modulation of obesity, diabetes and energy imbalance
Inventor: COLLIER GREGORY
IPC: A61K48/00
Filed: 2000-06-29
Abstract: An isolated nucleic acid molecule or derivative or homologue thereof comprising a nucleotide sequence encoding or complementary to B38, B55 or B60 or derivative, homologue or mimetic of said B38, B55 or B60 wherein said B38, B55 or B60 nucleic acid molecule is differentially expressed in liver tissue of obese animals compared to lean animals. (62) Divided out of 516211
Patent NZ-532626-A (NZ)
Title: Fixing assemblies and methods
Inventor: HENLY NICHOLAS CHARLES
IPC: F16B39/24
Filed: 2004-04-29
Abstract: An assembly of a watercraft appliance and one or more threaded fastening elements, the appliance being for attachment to a surface of a watercraft using said threaded fastening elements and cooperating elements threadable on the threaded fastening elements, wherein each fastening element is retained in an aperture in the appliance, each threaded fastening element being held against rotation with respect to the appliance by a retaining element up to a threshold torque, the retaining element allowing rotation of the threaded fastening element at torques higher than the threshold torque.
Patent NZ-538636-A (NZ)
Title: Solid formulations comprising an indolinone compound
Inventor: GATTI PAOLO
IPC: A61K31/404
Filed: 2003-09-10
Abstract: Solid formulations of indolinones are disclosed, wherein the formulations comprise 15-40 % w/w of an indolinone of formula (I), 10-86 % w/w of one or more pharmaceutically acceptable diluents, 2-20 % w/w of one or more pharmaceutically acceptable binders, 2-20 % w/w of one or more pharmaceutically acceptable disintegrants, and1-10 % w/w of one or more pharmaceutically acceptable lubricants, wherein the variables shown in formula (I) are as defined in the specification. These solid formulations are suitable for parenteral or oral administration. The formulations and the compounds themselves are useful for the treatment of protein kinase related disorders. In one embodiment the solid formulation comprises 40 % w/w of an indolinone of formula (I), or a pharmaceutically acceptable salt thereof, 47.5 % w/w mannitol, 6 % w/w croscaramellose sodium, 5 % w/w povidone and 1.5 % w/w magnesium stearate.
Patent NZ-538934-A (NZ)
Title: System for mapping payload data using a XML list into a spreadsheet
Inventor: LEUNG YIU-MING
IPC: G06F17/30
Filed: 2005-03-18
Abstract: A system for mapping payload data to spreadsheet lists comprises a spreadsheet storage unit; a payload data storage unit and a mapping unit. The spreadsheet storage unit is adapted to store spreadsheet data including at least one spreadsheet list. The at least one spreadsheet list includes at least one path associated with a field. The payload data storage unit is adapted to store payload data. The mapping unit is adapted to receive spreadsheet data from the spreadsheet storage unit, receive payload data from the payload data storage unit, and map the payload data to the at least one spreadsheet list by generating a set of parent paths for the at least one path; determining a longest parent path of the set of parent paths, designating a parent path of the set of parent paths as a bottom path and generating a set of nodes from payload data. The set of nodes is generated by evaluating the bottom path of the payload data. The at least one spreadsheet list includes extensible markup language (XML) lists.
Patent NZ-540014-A (NZ)
Title: A shoe fastener
Inventor: SINCLAIR SAMUEL JOHN
IPC: A43C11/12
Filed: 2005-05-12
Abstract: Disclosed is a shoe fastener to lace together two opposed lace receivable eyelets of a shoe upper, the fastener comprising: - an elongate rigid crossbar including a generally central region intermediate of opposed distal ends of the crossbar, - two eyelet-engageable portions, each mounted from the cross bar to engage with a respective of the two opposed lace receivable eyelets at least one of the two eyelet enagageable portions mounted to the crossbar to be movable relative to the crossbar so that the eyelet engageable portions can remain engageable with a respective of the opposed eyelets over a range of relative spatial dispositions of the opposed eyelets.
Patent NZ-541960-A (NZ)
Title: Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
Inventor: ATKINSON HARTLEY CAMPBELL
IPC: A61P11/02
Filed: 2005-06-17
Abstract: Disclosed is a pharmaceutical composition including about 2.5 mg loratadine, or a corresponding amount in the form of a suitable salt thereof, together with a hydroxy-alpha-[(methylamino)methyl]-benzenemethanol such as phenylephrine, or a suitable salt thereof, for use in a method of treating upper respiratory/mucosal congestion by administering to a patient four times a day. Also disclosed is a container containing a syrup including loratadine and phenylephrine, or suitable salts thereof, at concentrations suitable for administration of about 2.5 mg loratadine and about 8 to 10 mg phenylephrine per unit dose, the container including instructions to administer an amount of syrup that will deliver about 2.5 mg loratadine and about 8 to 10 mg phenylephrine per unit dose 4 times a day. Also disclosed theuse of the above in the treatment of upper respiratory mucosal congestion.
Patent NZ-547200-A (NZ)
Title: System and method for verifying connection of correct fluid supply to an infusion pump
Inventor: VANDERVEEN TIMOTHY W
IPC: A61M5/142
Filed: 2004-11-12
Abstract: A system and method for verifying that a particular fluid supply is connected to an infusion pump or pump channel are disclosed. An upstream pressure sensor coupled to a fluid conduit associated with the fluid supply is used to provide pressure signals in response to pressure sensed in the conduit to a processor. In a connection verification mode, the processor is configured to receive the pressure signals and delay the flow control device of the infusion pump from moving fluid through the conduit until the processor detects a pressure change in the conduit indicated by the pressure signals to thereby verify that the particular fluid supply is connected to the infusion pump.
Patent NZ-548384-A (NZ)
Title: Method of administering azithromycin
IPC: A61P31/04
Filed: 1995-04-28
Abstract: An oral dosage form of azithromycin which does not exhibit an adverse food effect; Specific azithromycin oral dosage forms including tablets, powders for oral suspensions and unit dose packets; Methods of treating microbial infections with the dosage forms; And therapeutic packages containing the dosage forms. (62) Divided Out of 537414
Patent NZ-550123-A (NZ)
Title: Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
Inventor: KLAENHAMMER TODD ROBERT
Filed: 2005-03-08
Abstract: Disclosed is an isolated nucleic acid selected from the group consisting of: a) a nucleic acid comprising a nucleotide sequence as set forth in SEQ ID NO:175; b) a nucleic acid comprising a nucleotide sequence having at least 85% sequence identity to a nucleotide sequence as set forth in SEQ ID NO:175 wherein said nucleic acid encodes a polypeptide having lactose permease activity; c) a nucleic acid comprising a fragment of a nucleotide sequence as set forth in SEQ ID NO:175 wherein said nucleic acid encodes a polypeptide having lactose permease activity; d) a nucleic acid that encodes a polypeptide comprising an amino acid sequence as set forth in SEQ ID NO:176 wherein said nucleic acid encodes a polypeptide having lactose permease activity; e) a nucleic acid comprising a nucleotide sequence encoding a polypeptide having at least 85% amino acid sequence identity to the amino acid sequence as set forth in SEQ ID NO:176 wherein said nucleic acid encodes a polypeptide having lactose permease activity and, f) a nucleic acid that hybridizes under stringent conditions to any of a)-e).
Patent NZ-551054-A (NZ)
Title: Carton and carton blank with reinforced top
Inventor: BLIN PATRICK
IPC: B65D5/468
Filed: 2005-04-08
Abstract: Disclosed is a two part carton which includes a first part with a number of wall panels forming an open top container and a separate second part forming a top closure which closes the open top container. The upper periphery of the open top container is reinforced by a series of integral reinforcing panels hinged around the upper periphery of the open top container. Each reinforcing panel is disposed in overlapping relationship with a respective one of the wall panels of the open top container. Each reinforcing panel is hinged to at least one adjacent reinforcing panel.
Patent NZ-551994-A (NZ)
Title: Vapour-phase hydrogenation of glycerol
Inventor: TUCK MICHAEL WILLIAM
IPC: C07C29/60
Filed: 2006-06-30
Abstract: Disclosed is a process for hydrogenation of glycerol in which a feed comprising glycerol is contacted with a stream of a hydrogen-containing gas and subjected to hydrogenation in the vapour phase in the presence of a catalyst at a temperature of from about 160 degrees C to about 260 degrees C a pressure of from about 10 to about 30 bar, a hydrogen to glycerol ratio of from 400:1 to about 600:1 and a residence time of from about 0.01 to about 2.5 seconds, to be selectively converted into a 1,2-propanediol or propanol as the major product.
Patent NZ-554640-A (NZ)
Title: New histone deacetylases inhibitors
Inventor: MINUCCI SAVERIO
IPC: A61P35/00
Filed: 2005-09-30
Abstract: Disclosed are compounds of formula (I), wherein A is phenyl or pyridinyl, R1 is -=-=-, -(C=Y)-=- or -=-(C=Y)- and the remaining substituents are as defined in the specification. The compounds are histone deacetylase inhibitors having antitumor activity.